-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QPO9KAscb73s5s62LjAZQGYZBTiszmjtCPkAc2tvJwgnuTljltWYPl/CHqsg9S+j Lup3VD62MhNmHMJCUtDztA== 0001193125-07-136835.txt : 20070615 0001193125-07-136835.hdr.sgml : 20070615 20070615170203 ACCESSION NUMBER: 0001193125-07-136835 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070615 DATE AS OF CHANGE: 20070615 EFFECTIVENESS DATE: 20070615 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENPATH MEDICAL, INC. CENTRAL INDEX KEY: 0000833140 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411533300 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-19467 FILM NUMBER: 07923812 BUSINESS ADDRESS: STREET 1: 2300 BERKSHIRE LANE NORTH CITY: PLYMOUTH STATE: MN ZIP: 55441 BUSINESS PHONE: 763-951-8181 MAIL ADDRESS: STREET 1: 2300 BERKSHIRE LANE NORTH CITY: PLYMOUTH STATE: MN ZIP: 55441 FORMER COMPANY: FORMER CONFORMED NAME: ENPATH MEDICAL INC DATE OF NAME CHANGE: 20040202 FORMER COMPANY: FORMER CONFORMED NAME: MEDAMICUS INC DATE OF NAME CHANGE: 19960330 15-12G 1 d1512g.htm FORM 15 Form 15

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

Certification and Notice of Termination of Registration under Section 12(g) of the Securities Exchange Act Of 1934 or Suspension of Duty to File Reports Under Sections 13 and 15(d) of the Securities Exchange Act of 1934.

Commission File Number: 0-019467

Enpath Medical, Inc.

(Exact name of registrant as specified in its charter)

2300 Berkshire Lane North

Minneapolis, Minnesota

55441-4684

(763) 951-8181

(Address, including zip code, and telephone number,

including area code, of registrant’s principal executive offices)

Common Stock, $.01 Par Value

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to

file reports under section 13(a) or 15(d) remains)

Please place an X in the boxes to designate the appropriate rule provisions relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)(i)    x       Rule 12h-3(b)(1)(ii)    ¨
Rule 12g-4(a)(1)(ii)    ¨       Rule 12h-3(b)(2)(i)    ¨
Rule 12g-4(a)(2)(i)    ¨       Rule 12h-3(b)(2)(ii)    ¨
Rule 12g-4(a)(2)(ii)    ¨       Rule 15d-6    ¨
Rule 12h-3(b)(1)(i)    x         

Approximate number of holders of record as of the certification or notice date: One holder

Pursuant to the requirements of the Securities Exchange Act of 1934, Enpath Medical, Inc. caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

DATE: June 15, 2007    BY:    /s/ Scott P. Youngstrom
      Scott P. Youngstrom
      Chief Financial Officer

 

 -----END PRIVACY-ENHANCED MESSAGE-----